Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
Profiles '''[[How to use QIBA Profiles|may be of use]]''' at any Stage. | Profiles '''[[How to use QIBA Profiles|may be of use]]''' at any Stage. | ||
| − | ===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Clinically Feasible (formerly Technically Confirmed Profiles | + | ===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Clinically Feasible (formerly Technically Confirmed) Profiles=== |
| − | *[[Media: | + | *[[Media:Supplement QIBA AmyloidPET 3Jun2022 TechnicallyConfirmed.pdf| PET Amyloid 2022-06-03]] |
*[[Media:MRE-QIBAProfile-2022-02-14-TECHNICALLY-CONFIRMED.pdf| MR Elastography of the Liver 2022-02-14]] | *[[Media:MRE-QIBAProfile-2022-02-14-TECHNICALLY-CONFIRMED.pdf| MR Elastography of the Liver 2022-02-14]] | ||
| Line 13: | Line 13: | ||
* [[Media:QIBA CT Vol SmallLungNoduleAssessmentInCTScreening 2018.11.18-clean-4.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]] | * [[Media:QIBA CT Vol SmallLungNoduleAssessmentInCTScreening 2018.11.18-clean-4.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]] | ||
| − | * [[Media: | + | * [[Media:QIBACTVol TumorVolumeChange(2022)-20220701.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-01 Streamlined Profile]] |
:* 32 pages including Conformance Checklists | :* 32 pages including Conformance Checklists | ||
Revision as of 20:07, 19 July 2022
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Profiles may be of use at any Stage.
Stage 3: Clinically Feasible (formerly Technically Confirmed) Profiles
- 32 pages including Conformance Checklists
Stage 2: Consensus Profiles
- CT Lung Density Profile_09.04.2020, clean version (Contains Conformance Checklist, Appendix B) 2020-10-23
- US Shear Wave Speed for Liver Fibrosis-2022-04-25 (closed on May 3, 2022)
- Appendix E: SWS Checklists (updated April 25, 2022)
Stage 1: Public Comment Profiles
Please submit comments using the online form
- MR DCE-MRI Quantification (DCEMRI-Q) 2020-10-12 (closed on March 10, 2021)
- MR MSK cartilage for joint disease 2020-05-18 (closed on October 29, 2020)
- fMRI for Sensorimotor Mapping 2017-06-19 (closed on December 31, 2017)
Comment Resolutions are posted for Past Public Comments and Past Technical Confirmations.
Format for Citing Profiles
Cite QIBA Profile documents as:
- Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. Date. Available from: URL
Example:
- QIBA MR Biomarker Committee. MR Elastography of the Liver, Quantitative Imaging Biomarkers Alliance. Profile Stage: Consensus. June 6, 2019. Available from: http://qibawiki.rsna.org/index.php/Profiles
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)